Jones Financial Companies’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.3M | Buy |
|
|||||
2025
Q1 | $11.7M | Buy |
|
|||||
2024
Q4 | $8.3M | Buy |
|
|||||
2024
Q3 | $4.82M | Buy |
|
|||||
2024
Q2 | $1.87M | Buy |
|
|||||
2024
Q1 | $1.15M | Buy |
|
|||||
2023
Q4 | $821K | Sell |
|
|||||
2023
Q3 | $935K | Buy |
|
|||||
2023
Q2 | $817K | Buy |
|
|||||
2023
Q1 | $811K | Sell |
|
|||||
2022
Q4 | $879K | Buy |
|
|||||
2022
Q3 | $777K | Sell |
|
|||||
2022
Q2 | $939K | Sell |
|
|||||
2022
Q1 | $1.03M | Buy |
|
|||||
2021
Q4 | $813K | Sell |
|
|||||
2021
Q3 | $795K | Sell |
|
|||||
2021
Q2 | $985K | Sell |
|
|||||
2021
Q1 | $1M | Buy |
|
|||||
2020
Q4 | $691K | Buy |
|
|||||
2020
Q3 | $647K | Buy |
|
|||||
2020
Q2 | $597K | Buy |
|
|||||
2020
Q1 | $497K | Buy |
|
|||||
2019
Q4 | $525K | Buy |
|
|||||
2019
Q3 | $388K | Sell |
|
|||||
2019
Q2 | $738K | Buy |
|
|||||
2019
Q1 | $495K | Sell |
|
|||||
2018
Q4 | $817K | Sell |
|
|||||
2018
Q3 | $1.22M | Buy |
|
|||||
2018
Q2 | $1.05M | Sell |
|
|||||
2018
Q1 | $1.22M | Buy |
|
|||||
2017
Q4 | $838K | Buy |
|
|||||
2017
Q3 | $612K | Buy |
|
|||||
2017
Q2 | $365K | Buy |
|
|||||
2017
Q1 | $275K | Buy |
|
|||||
2016
Q4 | $270K | Sell |
|
|||||
2016
Q3 | $303K | Sell |
|
|||||
2016
Q2 | $1.32M | Buy |
|
|||||
2016
Q1 | $237K | Buy |
|
|||||
2014
Q1 | – | Sell |
|
|||||
2013
Q4 | $1.29M | Buy |
|
|||||
2013
Q3 | $1.01M | Sell |
|
|||||
2013
Q2 | $1.7M | Buy |
|